Loading chart…
LIVE
Nectar Lifesciences Limited manufactures, distributes, markets and sells pharmaceutical products in India and internationally. The company offers cephalosporins, includes pharmaceutical ingredients and intermediates comprising cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine.
Nectar Lifesciences Limited (NECLIFE) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The NECLIFE share price is ₹10.28 (+0.78% today), with a market capitalisation of ₹2B and a price-to-earnings (P/E) ratio of 29.4. MarketRipple tracks the NECLIFE investment thesis, the ripple-chain impact of market events on Nectar Lifesciences Limited, and the Healthcare sector outlook.
Open
₹10.15
High
₹10.44
Low
₹10.05
Prev. Close
₹10.20
52W High
₹22.40
52W Low
₹9.30
Day range
₹10.05–₹10.44
52-week range
₹9.30–₹22.40
Volume
41K
P/E
29.4
ROE
-50.3%
D/E
0.00
Margin
0.0%
Nectar Lifesciences Limited (NSE: NECLIFE) is currently trading at ₹10.28 (+0.78%).
Nectar Lifesciences Limited's market capitalization is ₹2B.
Nectar Lifesciences Limited's price-to-earnings (P/E) ratio is 29.4.
Nectar Lifesciences Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).